Altesa Biosciences

Protecting Lungs. Improving Lives.

College Park, United States · $114.0M raised

Employees
1–10
Business Model
B2B
Total Funding
$114.0M
Last Round
$75.0M Series BFeb 2026
Rounds
3

About

Altesa BioSciences is a clinical-stage pharmaceutical company focused on developing antiviral therapies to protect people with chronic lung diseases from life-threatening respiratory virus infections. The company's primary program targets rhinovirus — the most common respiratory pathogen and the leading trigger of acute exacerbations in COPD and asthma patients — with an oral antiviral medicine (vapendavir) intended to prevent hospitalization and long-term lung function decline. Altesa's pipeline addresses a significant unmet need, as COPD affects 18.6 million Americans and generates an estimated $6.24 trillion in direct US medical costs between 2025 and 2050.

Summary

Altesa Biosciences is a Biotech company based in College Park, United States. It has raised $114.0M in total across 3 rounds, most recently a $75.0M Series B round in Feb 2026. Investors include Forbion Capital Partners, Pitango Growth and Sanofi Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BFeb 2026
$75.0M

Sign up to see all 3 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Altesa Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/altesa-biosciences"><img src="https://indexed.vc/api/badge/company/altesa-biosciences" alt="Altesa Biosciences on Indexed.vc" width="260" height="76" /></a>